Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

CT opioid lawsuits advancing in face of settlement effort

  • Health
  • by Ana Radelat
  • April 12, 2018
  • View as "Clean Read" "Exit Clean Read"

Washington – Nearly two dozen Connecticut cities and towns are scheduled to soon confront Purdue Phama and other opioid makers in court over what they say are the pharmaceuticals’ deceptive practices.

Meanwhile, a federal judge in Ohio is trying to resolve through a massive settlement more than 400 federal lawsuits brought by cities, counties and Native American tribes against central figures in the national opioid tragedy.

But, at least for now, Connecticut’s towns, including Waterbury, Bristol, East Hartford and Torrington, have chosen to sue Purdue and other opioid makers in state court. They have standing to do so because Purdue Pharma is based in Stamford.

Judy Scolnick, an attorney in the New York office of Scott + Scott, who represents Waterbury, New Haven, Bridgeport and New Britain, said the towns have until now rejected the massive settlement effort and plan to continue to pursue the case in state court because they think that’s’ “where the defendants’ liability risk is the greatest.”

Scolnick said the towns want the case tried by “a jury of the victims’ peers” — jurors who have had a family member, friend or co-worker fall victim to the opioid epidemic.

“Probably all of them have been touched,” Scolnick said of prospective jurors.

Connecticut had the 12th-highest number of opioid deaths in the country as of 2015, according to the U.S. Centers for Disease Control and Prevention.

The cases in Connecticut against the opioid makers have been joined, meaning they will be considered together, and will be heard in Hartford by Superior Court Judge Thomas Moukawsher.

The judge has laid out a quick schedule. The defendants must file their motions to dismiss the case by May 14. Defendants include Purdue, which makes OxiContin, and Allergan, Cephalon and Janssen Pharmaceuticals, which make oxycodone — which is similar to OxyContin but is not produced in a time-release form.

Another defendant is Endo Pharmaceutical, the maker of Opana ER, a long-acting opioid painkiller. Endo last year pulled it from the market after the FDA said the drug’s benefit did not outweigh public health risks associated with opioid abuse.

Endo denies the allegations and intends to vigorously defend the case, the company said in a statement.

www.CtMirror.org

Superior Court Judge Thomas Moukawsher

“Endo is dedicated to providing safe, quality products to patients in need, and we share the public concern regarding opioid abuse and misuse,” the statement said. “We are committed to working collaboratively to develop and implement a comprehensive solution to the opioid crisis, which is a complex problem with several causes that are difficult to disentangle.”

According to Mouskawsher’s order, defendants must file their response by June 13. If the case goes forward, oral arguments will be heard on June 28.

Connecticut’s cities are also suing major drug distributors, like McKesson and Cardinal Health, claiming they shipped alarming quantities without reporting to the authorities. Some cities also are suing several doctors considered “key opinion leaders” because they promoted in public forums, the use of opioids, saying they were safe.

New Haven, New Britain, Naugatuck, Southbury, Woodbury, Fairfield, Beacon Falls, Milford, Oxford, West Haven, North Haven, Thomaston, East Hartford, Southington, Newtown, Shelton and Tolland are also plaintiffs in the four opioid lawsuits in the state that have been consolidated before Moushkawsher.

Lawyers representing these towns say they expect additional Connecticut towns to join the lawsuits.

“By virtue of their deceptive and fraudulent marketing campaign, defendants have given rise to a drug epidemic the likes of which the Connecticut municipalities, the state of Connecticut, and the nation have never before seen, resulting in substantial economic harm to plaintiffs,” the complaints say.

Purdue and other opioid makers say their products are safe when used as prescribed and they are proactively warning patients against the dangers of misuse.

“We are deeply troubled by the prescription and illicit opioid abuse crisis, and we are dedicated to being part of the solution,” Purdue said in a statement. “As a company grounded in science, we must balance patient access to FDA-approved medicines, while working collaboratively to solve this public health challenge.”

John Parker, senior vice president of the Healthcare Distribution Alliance, a national organization representing drug distributors, said “given our role, the idea that distributors are responsible for the number of opioid prescriptions written defies common sense and lacks understanding of how the pharmaceutical supply chain actually works and is regulated.”

“Those bringing lawsuits would be better served addressing the root causes, rather than trying to redirect blame through litigation,” he said in a statement.

Plaintiffs say the drug companies knew of the dangers of prescribing opioids for chronic pain, that they knew the effectiveness of their drugs as pain killers wane over time — leading to higher doses and increasing use — and that the drug companies spent millions on marketing campaigns aimed at persuading doctors that they could be safely prescribed for a long term.

“Opioids are basically heroin pills,” Scolnick said.

The towns’ complaints include claims of violations of the Connecticut Unfair Trade Practices Act, public nuisance, fraud, negligent misrepresentation, innocent misrepresentation and unjust enrichment.

The towns are seeking compensatory damages to reimburse them for all the money the spent providing health care and other aid to opioid users as well as punitive damages.

A settlement in the works?

Meanwhile, federal Judge Dan Aaron Polster of the Northern District of Ohio has taken an unusual legal approach to the opioid lawsuits.

Late last year, a judicial panel gathered all the prescription opioid cases filed in federal court across the country in a consolidation called a multidistrict litigation, or MLD, and assigned them to Polster.

Instead of going through the arduous and time- consuming process of discovery and trial, Polster informed the army of lawyers involved in these cases he intended to prepare for settlement discussions immediately.

Kyle Constable :: CTMirror.org file photo

Attorney General George Jepsen

“I don’t think anyone in the country is interested in a whole lot of finger-pointing at this point, and I’m not either,” Polster told attorneys from across the country who flooded his courtroom in downtown Cleveland in a January meeting. “People aren’t interested in figuring out the answer to interesting legal questions like preemption and learned intermediary, or unraveling complicated conspiracy theories. So, my objective is to do something meaningful to abate this crisis and to do it in 2018.”

Polster has scheduled a May 9 settlement conference and wants everyone involved in an opioid suit, including those suing in state courts, to participate. But it’s not clear whether Connecticut towns will join the effort.

“The federal MDL is at this point distinct from the Connecticut action,” said Sarah Burn, an attorney for the Simmons Hanly Conroy law firm that is representing Bridgeport and 17 other Connecticut towns in their opioid suit.

Connecticut Attorney General George Jepsen, however, said he’ll be involved.

Jepsen is among 41 state attorneys general invited to the settlement conference by Polster. Some of the attorneys general have sued the pharmaceutical companies over their opioid marketing and distribution; others, like Jepsen, launched investigations into those companies.

Jepsen said when a group of state attorneys generals began their investigation 14 months ago, their main target was Purdue Pharma. When he was asked to become more involved, Jepsen moved to include other pharmaceutical companies in the probe, as well as major drug distributors.

Jepsen lauded Polster’s attempts to reach a “global settlement,” much like the tobacco settlement that ended a massive wave of litigation in the 1990s.

“We have come further in the past two-and-a-half months than in the previous years,” he said. “We are still far from a solution, but we are closer.”

Connecticut has received nearly $2 billion over the past 15 years as part of a legal settlement meant to compensate states for the toll of tobacco. But the nation’s pharmaceuticals have a stronger defense than the tobacco companies in that their product is used for legitimate medical purposes.

Still, there is a cost for the drug makers in defending hundreds of lawsuits. And Polster has experience with MDLs, having mediated settlements in some 700 cases involving a medical contrast dye.

Jepsen wants Connecticut’s cities and towns to be a part of any settlement.

“We don’t see a global solution unless the cities and towns are part of a final settlement,” Jepsen said.

It’s likely most of the money offered in a settlement would go to states like Connecticut that have had to pay hundreds of millions of dollars in Medicaid claims as a result of the epidemic of opioid addiction.

Jepsen said he’d press for any windfall Connecticut would receive from an opioid settlement to go to treatment and prevention services, “before the money is put in the general fund.”

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Ana Radelat Ana has written about politics and policy in Washington, D.C.. for Gannett, Thompson Reuters and UPI. She was a special correspondent for the Miami Herald, and a regular contributor to The New York TImes, Advertising Age and several other publications. She has also worked in broadcast journalism, for CNN and several local NPR stations. She is a graduate of the University of Maryland School of Journalism.

SEE WHAT READERS SAID

RELATED STORIES
How does the public option bill differ from Gov. Ned Lamont’s health care plan? Here’s a look at the two proposals.
by Jenna Carlesso

With the rising cost of care a central issue this legislative session, lawmakers and Gov. Ned Lamont’s administration have each moved ahead with their own plans aimed at driving down prices.

Rep. Patricia Billie Miller wins vacant Senate seat
by Mark Pazniokas

Rep. Patricia Billie Miller, D-Stamford, won a special election to the state Senate.

Final passage of ‘Crown Act’ comes on unanimous vote
by Mark Pazniokas

With a unanimous vote, Connecticut became the latest state to adopt legislation prohibiting discrimination based on hairstyles associated with race.

Senate confirms Miguel Cardona as U.S. Secretary of Education
by Adria Watson

Cardona was the youngest principal in the state of Connecticut.

Nora Dannehy named top legal aide to Lamont
by Mark Pazniokas

The hiring of Nora Dannehy brings a high-profile legal talent into Lamont's office at the mid-point of his four-year term.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion The Board of Regents’ changes must not shortchange its students or faculty
by Carrie Andreoletti, PhD

As a university professor and a lifespan developmental psychologist, I tend to approach my work from a developmental perspective. This means I aim to foster a lifelong love of learning and to help others find a sense of meaning and purpose, as well as confidence in their ability to reach their goals. My approach to higher education is shaped by my desire to provide the best possible education for my students. This is why the recent Board of Regents’ proposed changes at the four state universities have me worried.

Opinion How to close schooling opportunity gaps created by the pandemic
by Carol Gale

We ask school district leaders to trust your public servants whose daily work life involves assessing student needs and planning or modifying instruction to meet those needs. Listen to their voices, as we have, and allocate precious resources on interventions that will offer increased opportunities for Hartford students to succeed.

Opinion A new guide for schools: How to work with families this spring
by Michael Arrington and Erika Haynes

With months of remote and hybrid learning to go, families and educators continue to adapt and innovate to meet the moment. Since August, we’ve spoken with hundreds of parents, caregivers, family support groups, educators, and students across Connecticut and the country about things things that have worked --strategies, big and small, that have made this time more manageable and helped children learn and stay connected with peers.

Opinion Housing is a human right
by Tenaya Taylor

Nonprofit Accountability Group is a queer- and trans-led group based in Hartford that is dedicated to creating racial equity by directing resources to Black, Indigenous and People of Color (BIPOC) and disabled children and families. NAG was founded in 2020 as an organization with a transformative approach to implementing nonprofit accountability by creating relationships within the community, nonprofits, and their funders.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO